Genetic backgrounds and redox conditions influence morphological characteristics and cell differentiation of osteoclasts in mice

Cell and Tissue Research

Volumn 348, Issue 1, 2012, Pages 81-94

  Narahara, Shun ^a   Matsushima, Haruna ^a   Sakai, Eiko ^a   Fukuma, Yutaka ^a   Nishishita, Kazuhisa ^a   Okamoto, Kuniaki ^a   Tsukuba, Takayuki ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

BALB c; C57BL 6; ddY; Differentiation; Osteoclasts

Indexed keywords

ANIMAL CELL; ARTICLE; BACKGROUND SELECTION; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CELL DIFFERENTIATION; CELL SHAPE; CELL SIZE; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; GENETIC DIFFERENCE; INTRACELLULAR SIGNALING; MALE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACETYLCYSTEINE; ANIMALS; BIOLOGICAL MARKERS; BONE MARROW CELLS; CELL COUNT; CELL DIFFERENTIATION; CELL SHAPE; CELL SIZE; GENE EXPRESSION REGULATION; HYDROGEN PEROXIDE; INTRACELLULAR SPACE; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; OSTEOCLASTS; OSTEOGENESIS; OXIDATION-REDUCTION; RNA, MESSENGER; SIGNAL TRANSDUCTION;

MUS;

EID: 84859445154     PISSN: 0302766X     EISSN: 14320878     Source Type: Journal    
DOI: 10.1007/s00441-012-1325-8     Document Type: Article

References (41)

1. Autenrieth IB, Beer M, Bohn E, Kaufmann SH, Heesemann J (1994) Immune responses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/6 mice: an essential role for gamma interferon. Infect Immun 62:2590-2599 (Pubitemid 24157094)
2. Baker PJ, Dixon M, Roopenian DC (2000) Genetic control of susceptibility to Porphyromonas gingivalis-induced alveolar bone loss in mice. Infect Immun 68:5864-5868
3. Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423:337-342 (Pubitemid 40852708)
4. Brett SJ, Butler R (1986) Resistance to Mycobacterium lepraemurium is correlated with the capacity to generate macrophage activating factor(s) in response to mycobacterial antigens in vitro. Immunology 59:339-345 (Pubitemid 16007082)
5. Choi HG, Kim JM, Kim BJ, Yoo YJ, Cha JH (2007) Mouse straindependent osteoclastogenesis in response to lipopolysaccharide. J Microbiol 45:566-571
6. Delaisse JM, Andersen TL, Engsig MT, Henriksen K, Troen T, Blavier L (2003) Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities. Microsc Res Tech 61:504-513 (Pubitemid 36890583)
7. Fairweather D, Cihakova D (2009) Alternatively activated macrophages in infection and autoimmunity. J Autoimmun 33:222-230
8. Gerstenfeld LC, McLean J, Healey DS, Stapleton SN, Silkman LJ, Price C, Jepsen KJ (2010) Genetic variation in the structural pattern of osteoclast activity during post-natal growth of mouse femora. Bone 46:1546-1554
9. Guler ML, Gorham JD, Hsieh CS, Mackey AJ, Steen RG, Dietrich WF, Murphy KM (1996) Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development. Science 271:984-987
10. Ha H, Kwak HB, Lee SW, Jin HM, Kim HM, Kim HH, Lee ZH (2004) Reactive oxygen species mediate RANK signaling in osteoclasts. Exp Cell Res 301:119-127 (Pubitemid 39504965)
11. Hoft DF, Lynch RG, Kirchhoff LV (1993) Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi. J Immunol 151:7038-7047 (Pubitemid 24001078)
12. Hotokezaka H, Sakai E, Kanaoka K, Saito K, Matsuo K, Kitaura H, Yoshida N, Nakayama K (2002) U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells. J Biol Chem 277:47366-47372 (Pubitemid 36159251)
13. Hu JP, Nishishita K, Sakai E, Yoshida H, Kato Y, Tsukuba T, Okamoto K (2008) Berberine inhibits RANKL-induced osteoclast formation and survival through suppressing the NF-kappaB and Akt pathways. Eur J Pharmacol 580:70-79
14. Kamiya T, Kobayashi Y, Kanaoka K, Nakashima T, Kato Y, Mizuno A, Sakai H (1998) Fluorescence microscopic demonstration of cathepsin K activity as the major lysosomal cysteine proteinase in osteoclasts. J Biochem 123:752-759 (Pubitemid 28197496)
15. Kim MS, Yang YM, Son A, Tian YS, Lee SI, Kang SW, Muallem S, Shin DM (2010) RANKL-mediated reactive oxygen species pathway that induces long lasting Ca2+ oscillations essential for osteoclastogenesis. J Biol Chem 285:6913-6921
16. Kukita T, Wada N, Kukita A, Kakimoto T, Sandra F, Toh K, Nagata K, Iijima T, Horiuchi M, Matsusaki H, Hieshima K, Yoshie O, Nomiyama H (2004) RANKL-induced DC-STAMP is essential for osteoclastogenesis. J Exp Med 200:941-946 (Pubitemid 39362930)
17. Kuroda E, Noguchi J, Doi T, Uematsu S, Akira S, Yamashita U (2007) IL-3 is an important differentiation factor for the development of prostaglandin E2-producing macrophages between C57BL/6 and BALB/c mice. Eur J Immunol 37:2185-2195 (Pubitemid 47250211)
18. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176 (Pubitemid 28180851)
19. Launois P, Maillard I, Pingel S, Swihart KG, Xenarios I, Acha-Orbea H, Diggelmann H, Locksley RM, MacDonald HR, Louis JA (1997) IL-4 rapidly produced by V beta 4 Valpha 8 CD4+ T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice. Immunity 6:541-549 (Pubitemid 27239345)
20. Leakey AK, Ulett GC, Hirst RG (1998) BALB/c and C57Bl/6 mice infected with virulent Burkholderia pseudomallei provide contrasting animal models for the acute and chronic forms of human melioidosis. Microb Pathog 24:269-275 (Pubitemid 28266810)
21. Lee NK, Choi YG, Baik JY, Han SY, Jeong DW, Bae YS, Kim N, Lee SY (2005) A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 106:852-859 (Pubitemid 41076424)
22. Linkhart TA, Linkhart SG, Kodama Y, Farley JR, Dimai HP, Wright KR, Wergedal JE, Sheng M, Beamer WG, Donahue LR, Rosen CJ, Baylink DJ (1999) Osteoclast formation in bone marrow cultures from two inbred strains of mice with different bone densities. J Bone Miner Res 14:39-46 (Pubitemid 29021602)
23. Lomaga MA, Yeh WC, Sarosi I, Duncan GS, Furlonger C, Ho A, Morony S, Capparelli C, Van G, Kaufman S, van der Heiden A, Itie A, Wakeham A, Khoo W, Sasaki T, Cao Z, Penninger JM, Paige CJ, Lacey DL, Dunstan CR, Boyle WJ, Goeddel DV, Mak TW (1999) TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev 13:1015-1024 (Pubitemid 29200984)
24. Mantovani A, Sica A, Locati M (2007) New vistas on macrophage differentiation and activation. Eur J Immunol 37:14-16 (Pubitemid 46128780)
25. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM (2000) M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 164:6166-6173 (Pubitemid 30408793)
26. Murata Y, Shimamura T, Hamuro J (2002) The polarization of T(h)1/T (h)2 balance is dependent on the intracellular thiol redox status of macrophages due to the distinctive cytokine production. Int Immunol 14:201-212 (Pubitemid 34144744)
27. Raggatt LJ, Partridge NC (2010) Cellular and molecular mechanisms of bone remodeling. J Biol Chem 285:25103-25108
28. Rho J, Takami M, Choi Y (2004) Osteoimmunology: interactions of the immune and skeletal systems. Mol Cells 17:1-9 (Pubitemid 39137036)
29. Rivera J, Tessarollo L (2008) Genetic background and the dilemma of translating mouse studies to humans. Immunity 28:1-4
30. Suda T, Takahashi N, Martin TJ (1992) Modulation of osteoclast differentiation. Endocr Rev 13:66-80
31. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ (1999) Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20:345-357 (Pubitemid 30649812)
32. Takayanagi H (2009) Osteoimmunology and the effects of the immune system on bone. Nat Rev Rheumatol 5:667-676
33. Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, Wagner EF, Mak TW, Kodama T, Taniguchi T (2002) Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 3:889-901 (Pubitemid 35460788)
34. Tanaka S, Wakeyama H, Akiyama T, Takahashi K, Amano H, Nakayama KI, Nakamura K (2010) Regulation of osteoclast apoptosis by bcl-2 family protein bim and caspase-3. Adv Exp Med Biol 658:111-116
35. Teitelbaum SL, Ross FP (2003) Genetic regulation of osteoclast development and function. Nat Rev Genet 4:638-649 (Pubitemid 36917505)
36. Udagawa N, Takahashi N, Akatsu T, Tanaka H, Sasaki T, Nishihara T, Koga T, Martin TJ, Suda T (1990) Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci U S A 87:7260-7264
37. Udagawa N, Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, Itoh K, Nakagawa N, Yasuda H, Goto M, Tsuda E, Higashio K, Gillespie MT, Martin TJ, Suda T (1999) Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand. Bone 25:517-523 (Pubitemid 29469457)
38. Yang M, Birnbaum MJ, MacKay CA, Mason-Savas A, Thompson B, Odgren PR (2008) Osteoclast stimulatory transmembrane protein (OC-STAMP), a novel protein induced by RANKL that promotes osteoclast differentiation. J Cell Physiol 215:497-505 (Pubitemid 351468962)
39. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis- inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A 95:3597-3602
40. Yoshida H, Hayashi S, Kunisada T, Ogawa M, Nishikawa S, Okamura H, Sudo T, Shultz LD (1990) The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345:442-444 (Pubitemid 120014957)
41. Zhang C, Tang T, Ren W, Zhang X, Dai K (2008) Influence of mouse genetic background on wear particle-induced in vivo inflammatory osteolysis. Inflamm Res 57:211-215